Abstract:Objective To explore the clinical value of ultra-early minimally invasive surgery combined with medication in the treatment of hypertensive intracerebral hemorrhage and provide reference in the clinical treatment. Methods Ninety patients with hypertensive intracerebral hemorrhage treated from October 2016 to October 2017 were selected and divided into observation group and control group by random number table method(n=45, each). The routine treatment including routine minimally invasive surgery and routine Western medicine therapy was given in control group, and ultra-early minimally invasive surgery combined imtegrative Chinese and Western medicine was performed in observation group. The clinical effects were compared between two groups after treatment for 8 weeks. At the same time, the size of hematoma, the neurological deficit score (NDS), activity of daily living (ADL) before and after treatment and the incidence of complications were observed in two groups. Results The total effective rate in observation group was significantly higher than that in control group (73.33% vs 51.11%, χ²=4.727, P<0.05). There were no obvious differences in volume of hematoma, NDS and ADL between two groups before treatment (P>0.05). The hematoma volume, scores of NDS and ADL were improved in both two groups and was significantly better in observation group than those in control group (t=12.374, 13.259, 7.009, respectively, P<0.05). The incidence of complications in observation group was statistically lower than that in control group (37.78% vs 80.00%, χ²=16.568, P<0.05). Conclusion Ultra-early minimally invasive surgery combined with drug therapy in the treatment of hypertensive intracerebral hemorrhage has a good clinical effect that manifests in promoting hematoma absorption, improving nerve function and life ability and reducing the incidence of complications. At the same time, the mortality rate and disability rate can be effectively reduced.